FDA/NIH GENE THERAPY DATABASE FUTURE FUNDING IN QUESTION, CBER's NOGUCHI CAUTIONS RAC IN MEMO; CANCER GENE THERAPY, RARE DISEASE AND AIDS PROTOCOLS OKed

Future funding for the collaborative gene therapy database being created by FDA and the National Institutes of Health may be in jeopardy, FDA Division of Cellular and Gene Therapies Director Philip Noguchi, MD, warned in a memorandum presented to the National Institutes of Health Recombinant DNA Advisory Committee at its June 8-9 meeting in Bethesda, Md.